☆ 4.5 Article

Metabolomic changes related to airway inflammation, asthma pathogenesis and systemic activity following inhaled fluticasone furoate/vilanterol: a randomized controlled trial

RESPIRATORY RESEARCH (2022)

Related references

Note: Only part of the references are listed.

Article Biochemistry & Molecular Biology

Metabolomic profiling reveals extensive adrenal suppression due to inhaled corticosteroid therapy in asthma

Priyadarshini Kachroo et al.

Summary: The application of large-scale metabolomic profiling provides new opportunities for omics-based precision medicine in treating asthma. This study identifies and replicates 17 steroid metabolites that are significantly reduced in individuals with asthma, especially those receiving inhaled corticosteroid (ICS) treatment. The dose-dependent effect of ICS treatment on steroid levels suggests the need for regular cortisol monitoring to minimize the adverse effects of adrenal suppression. The findings highlight the importance of considering the public health implications of adrenal suppression in asthma patients receiving ICS treatment.

NATURE MEDICINE (2022)

Add to Collection

Article Pharmacology & Pharmacy

Therapeutic index of inhaled corticosteroids in asthma: A dose-response comparison on airway hyperresponsiveness and adrenal axis suppression

Peter T. Daley-Yates et al.

Summary: This study compared the airway potency, systemic activity, and therapeutic index of three inhaled corticosteroids. Fluticasone furoate (FF) showed greater airway potency and less systemic activity compared to fluticasone propionate (FP) and budesonide (BUD), suggesting that FF may provide better protection against airway hyperresponsiveness with a wider therapeutic index.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2021)

Add to Collection

Review Allergy

Metabolic Dysfunction and Asthma: Current Perspectives

Helena Pite et al.

JOURNAL OF ASTHMA AND ALLERGY (2020)

Add to Collection

Editorial Material Respiratory System

Metabolomics in the prevention and management of asthma

Zhaozhong Zhu et al.

EXPERT REVIEW OF RESPIRATORY MEDICINE (2019)

Add to Collection

Article Respiratory System

Anti-inflammatory duration of action of fluticasone furoate/vilanterol trifenatate in asthma: a cross-over randomised controlled trial

George Bardsley et al.

RESPIRATORY RESEARCH (2018)

Add to Collection

Article Respiratory System

Metabolomics analysis identifies different metabotypes of asthma severity

Stacey N. Reinke et al.

EUROPEAN RESPIRATORY JOURNAL (2017)

Add to Collection

Meeting Abstract Respiratory System

Late Breaking Abstract - The duration of anti-inflammatory action of fluticasone furoate (FF) assessed via exhaled nitric oxide (FeNO) in asthmatics following administration of FF/vilanterol (VI)

Peter Daley-Yates et al.

EUROPEAN RESPIRATORY JOURNAL (2017)

Add to Collection

Article Allergy

Urinary metabolomic profiling of asthmatics can be related to clinical characteristics

C. C. Loureiro et al.

ALLERGY (2016)

Add to Collection

Article Cardiac & Cardiovascular Systems

Randomised, double-blind, placebo-controlled, cross-over single dose study of the bronchodilator duration of action of combination fluticasone furoate/vilanterol inhaler in adult asthma

Irene Braithwaite et al.

RESPIRATORY MEDICINE (2016)

Add to Collection

Article Gastroenterology & Hepatology

Using Corticosteroids to Reshape the Gut Microbiome: Implications for Inflammatory Bowel Diseases

Edmond Y. Huang et al.

INFLAMMATORY BOWEL DISEASES (2015)

Add to Collection

Article Multidisciplinary Sciences

Glucocorticoid (dexamethasone)-induced metabolome changes in healthy males suggest prediction of response and side effects

Natalie Bordag et al.

SCIENTIFIC REPORTS (2015)

Add to Collection

Article Respiratory System

Plasma phospholipase A(2) activity in patients with asthma: association with body mass index and cholesterol concentration

N. L. A. Misso et al.

THORAX (2008)

Add to Collection

Article Physiology

Pharmacological properties of the enhanced-affinity glucocorticoid fluticasone furoate in vitro and in an in vivo model of respiratory inflammatory disease

Mark Salter et al.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2007)

Add to Collection

Review Respiratory System

Multiple roles of nitric oxide in the airways

FLM Ricciardolo

THORAX (2003)

Add to Collection

© Peeref 2019-2024. All rights reserved.